Difference in retinal age and real age linked to increased death risk

January 21, 2022

The difference between retina’s biological age and person’s real age linked to heightened death risk, with a team of Australian investigators finding that evidence suggests the microvasculature in the retina may be a reliable indicator of the overall health of the body’s circulatory system and the brain.

Ophthalmic bevacizumab effectively treats wet macular degeneration, NORSE TWO concludes

January 21, 2022

Firas Rahhal, MD, discusses Outlook Therapeutics’ Phase 3 pivotal NORSE TWO trial for ONS-5010.

Managing DME and increasing vision effectively with intravitreal triamcinolone

January 20, 2022

The improvement became evident during an average time of 6 months.

National Eye Institute grants funding to WVU to study the mechanism of retinal degeneration

January 19, 2022

According to researchers, gaining a good understanding of what Musashi proteins do and how to manipulate their function could lead to the development of a universal therapy for blinding diseases.

REGENXBIO announces second pivotal trial, ASCENT, in RGX-314 clinical program

January 18, 2022

ASCENT, REGENXBIO’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.

Pupillary sizes differ in active and resolved COVID-19 cases, study finds

January 18, 2022

The investigators believe that, based on their findings, the impact of COVID-19 on the autonomous nervous system warrants further prospective studies and assessment of pupillary function might be a useful test for determining autonomic dysfunction.

Inserting intravitreal dexamethasone implants in vitrectomized vs non-vitrectomized eyes

January 17, 2022

Consecutive intravitreal dexamethasone treatments may be beneficial for patients with DME patients who had undergone a previous vitrectomy.

Diagnosing Parkinson’s disease aided by OCT/OCTA ocular biomarkers

January 14, 2022

Imaging study revealed specific retinal and choroidal changes associated with the disease.

Investigating the quality of real-world evidence in retinal disease

January 13, 2022

Real-world evidence is growing in importance as a source of information that can help support clinical decision-making when evaluated properly.

Meeting the need of persistent long COVID-19 symptoms

January 12, 2022

Investigators have cited the need for pharmacologic and non-pharmacologic interventions to improve the ongoing burden after hospitalization for COVID-19.